Presenter: Dr. Afshin Safavi, Founder & Board Member at BioAgilytix
Co-Hosted with: Bioanalysis Zone
With the question ‘should we qualify or validate an exploratory biomarker assay before sample testing?’ in mind, Dr. Safavi will review and discuss the latest scientific and regulatory considerations for the analytical validation of assays for fluid-based biomarkers used in the qualification of drug development tools (DDTs). Topics will cover:
You can learn more about the topics Dr. Safavi covers in his pre-webinar blog.
Services
Platforms